These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33157036)

  • 1. A Small Molecule that Binds an RNA Repeat Expansion Stimulates Its Decay via the Exosome Complex.
    Angelbello AJ; Benhamou RI; Rzuczek SG; Choudhary S; Tang Z; Chen JL; Roy M; Wang KW; Yildirim I; Jun AS; Thornton CA; Disney MD
    Cell Chem Biol; 2021 Jan; 28(1):34-45.e6. PubMed ID: 33157036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fuchs' Endothelial Corneal Dystrophy and RNA Foci in Patients With Myotonic Dystrophy.
    Mootha VV; Hansen B; Rong Z; Mammen PP; Zhou Z; Xing C; Gong X
    Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4579-4585. PubMed ID: 28886202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationally designed small molecules that target both the DNA and RNA causing myotonic dystrophy type 1.
    Nguyen L; Luu LM; Peng S; Serrano JF; Chan HY; Zimmerman SC
    J Am Chem Soc; 2015 Nov; 137(44):14180-9. PubMed ID: 26473464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A CTG repeat-selective chemical screen identifies microtubule inhibitors as selective modulators of toxic CUG RNA levels.
    Reddy K; Jenquin JR; McConnell OL; Cleary JD; Richardson JI; Pinto BS; Haerle MC; Delgado E; Planco L; Nakamori M; Wang ET; Berglund JA
    Proc Natl Acad Sci U S A; 2019 Oct; 116(42):20991-21000. PubMed ID: 31570586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fuchs' Endothelial Corneal Dystrophy in Patients With Myotonic Dystrophy, Type 1.
    Winkler NS; Milone M; Martinez-Thompson JM; Raja H; Aleff RA; Patel SV; Fautsch MP; Wieben ED; Baratz KH
    Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3053-3057. PubMed ID: 30025114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA toxicity and missplicing in the common eye disease fuchs endothelial corneal dystrophy.
    Du J; Aleff RA; Soragni E; Kalari K; Nie J; Tang X; Davila J; Kocher JP; Patel SV; Gottesfeld JM; Baratz KH; Wieben ED
    J Biol Chem; 2015 Mar; 290(10):5979-90. PubMed ID: 25593321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precise small-molecule cleavage of an r(CUG) repeat expansion in a myotonic dystrophy mouse model.
    Angelbello AJ; Rzuczek SG; Mckee KK; Chen JL; Olafson H; Cameron MD; Moss WN; Wang ET; Disney MD
    Proc Natl Acad Sci U S A; 2019 Apr; 116(16):7799-7804. PubMed ID: 30926669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precise small-molecule recognition of a toxic CUG RNA repeat expansion.
    Rzuczek SG; Colgan LA; Nakai Y; Cameron MD; Furling D; Yasuda R; Disney MD
    Nat Chem Biol; 2017 Feb; 13(2):188-193. PubMed ID: 27941760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trinucleotide Repeat-Targeting dCas9 as a Therapeutic Strategy for Fuchs' Endothelial Corneal Dystrophy.
    Rong Z; Gong X; Hulleman JD; Corey DR; Mootha VV
    Transl Vis Sci Technol; 2020 Aug; 9(9):47. PubMed ID: 32934897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TCF4 Triplet Repeat Expansion and Nuclear RNA Foci in Fuchs' Endothelial Corneal Dystrophy.
    Mootha VV; Hussain I; Cunnusamy K; Graham E; Gong X; Neelam S; Xing C; Kittler R; Petroll WM
    Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):2003-11. PubMed ID: 25722209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico discovery of substituted pyrido[2,3-d]pyrimidines and pentamidine-like compounds with biological activity in myotonic dystrophy models.
    González ÀL; Konieczny P; Llamusi B; Delgado-Pinar E; Borrell JI; Teixidó J; García-España E; Pérez-Alonso M; Estrada-Tejedor R; Artero R
    PLoS One; 2017; 12(6):e0178931. PubMed ID: 28582438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting toxic RNAs that cause myotonic dystrophy type 1 (DM1) with a bisamidinium inhibitor.
    Wong CH; Nguyen L; Peh J; Luu LM; Sanchez JS; Richardson SL; Tuccinardi T; Tsoi H; Chan WY; Chan HY; Baranger AM; Hergenrother PJ; Zimmerman SC
    J Am Chem Soc; 2014 Apr; 136(17):6355-61. PubMed ID: 24702247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligonucleotides targeting TCF4 triplet repeat expansion inhibit RNA foci and mis-splicing in Fuchs' dystrophy.
    Hu J; Rong Z; Gong X; Zhou Z; Sharma VK; Xing C; Watts JK; Corey DR; Mootha VV
    Hum Mol Genet; 2018 Mar; 27(6):1015-1026. PubMed ID: 29325021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationally designed small molecules targeting the RNA that causes myotonic dystrophy type 1 are potently bioactive.
    Childs-Disney JL; Hoskins J; Rzuczek SG; Thornton CA; Disney MD
    ACS Chem Biol; 2012 May; 7(5):856-62. PubMed ID: 22332923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The TCF4 Trinucleotide Repeat Expansion of Fuchs' Endothelial Corneal Dystrophy: Implications for the Anterior Segment of the Eye.
    Hu J; Gong X; Johnson ST; Corey DR; Mootha VV
    Invest Ophthalmol Vis Sci; 2023 May; 64(5):16. PubMed ID: 37204786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel CUG(exp)·MBNL1 inhibitor with therapeutic potential for myotonic dystrophy type 1.
    Jahromi AH; Nguyen L; Fu Y; Miller KA; Baranger AM; Zimmerman SC
    ACS Chem Biol; 2013 May; 8(5):1037-43. PubMed ID: 23480597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of pharmacophore models for small molecules targeting RNA: Application to the RNA repeat expansion in myotonic dystrophy type 1.
    Angelbello AJ; González ÀL; Rzuczek SG; Disney MD
    Bioorg Med Chem Lett; 2016 Dec; 26(23):5792-5796. PubMed ID: 27839685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A flow cytometry-based screen identifies MBNL1 modulators that rescue splicing defects in myotonic dystrophy type I.
    Zhang F; Bodycombe NE; Haskell KM; Sun YL; Wang ET; Morris CA; Jones LH; Wood LD; Pletcher MT
    Hum Mol Genet; 2017 Aug; 26(16):3056-3068. PubMed ID: 28535287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeat-Associated Non-ATG (RAN) Translation in Fuchs' Endothelial Corneal Dystrophy.
    Soragni E; Petrosyan L; Rinkoski TA; Wieben ED; Baratz KH; Fautsch MP; Gottesfeld JM
    Invest Ophthalmol Vis Sci; 2018 Apr; 59(5):1888-1896. PubMed ID: 29677349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanded DNA and RNA Trinucleotide Repeats in Myotonic Dystrophy Type 1 Select Their Own Multitarget, Sequence-Selective Inhibitors.
    Hagler LD; Luu LM; Tonelli M; Lee J; Hayes SM; Bonson SE; Vergara JI; Butcher SE; Zimmerman SC
    Biochemistry; 2020 Sep; 59(37):3463-3472. PubMed ID: 32856901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.